Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
15.23
+0.04 (0.26%)
At close: Sep 15, 2025, 4:00 PM EDT
15.23
0.00 (0.00%)
After-hours: Sep 15, 2025, 4:10 PM EDT
Bausch + Lomb Revenue
Bausch + Lomb had revenue of $1.28B in the quarter ending June 30, 2025, with 5.10% growth. This brings the company's revenue in the last twelve months to $4.89B, up 8.81% year-over-year. In the year 2024, Bausch + Lomb had annual revenue of $4.79B with 15.56% growth.
Revenue (ttm)
$4.89B
Revenue Growth
+8.81%
P/S Ratio
1.10
Revenue / Employee
$362,296
Employees
13,500
Market Cap
5.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BLCO News
- 7 days ago - Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 days ago - Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States - Business Wire
- 27 days ago - Bausch + Lomb Announces Board Changes - Business Wire
- 4 weeks ago - Bausch + Lomb to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Bausch + Lomb Corporation (BLCO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bausch + Lomb Announces Second-Quarter 2025 Results - Business Wire
- 2 months ago - Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye - Business Wire
- 2 months ago - Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13 - Business Wire